Recuvyra

RSS

Expired

This medicine's authorisation has expired

fentanyl
MedicineVeterinaryExpired

Danish is available via eTranslation, the European Commission's machine translation service.

Translate to Danish | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for Recuvyra has expired following the marketing-authorisation holder’s decision not to apply for a renewal.

български (BG) (568.84 KB - PDF)

Vis

español (ES) (537.02 KB - PDF)

Vis

čeština (CS) (573.8 KB - PDF)

Vis

dansk (DA) (511.6 KB - PDF)

Vis

Deutsch (DE) (515.35 KB - PDF)

Vis

eesti (ET) (539.37 KB - PDF)

Vis

ελληνικά (EL) (586.2 KB - PDF)

Vis

français (FR) (538.28 KB - PDF)

Vis

italiano (IT) (535.2 KB - PDF)

Vis

latviešu (LV) (569.81 KB - PDF)

Vis

lietuvių (LT) (534.12 KB - PDF)

Vis

magyar (HU) (548.34 KB - PDF)

Vis

Malti (MT) (576.33 KB - PDF)

Vis

Nederlands (NL) (513.44 KB - PDF)

Vis

polski (PL) (552.75 KB - PDF)

Vis

português (PT) (535.52 KB - PDF)

Vis

română (RO) (533.59 KB - PDF)

Vis

slovenčina (SK) (570.05 KB - PDF)

Vis

slovenščina (SL) (564.24 KB - PDF)

Vis

suomi (FI) (533.75 KB - PDF)

Vis

svenska (SV) (535.74 KB - PDF)

Vis

Product information

български (BG) (1.46 MB - PDF)

Vis

español (ES) (876.92 KB - PDF)

Vis

čeština (CS) (1.18 MB - PDF)

Vis

dansk (DA) (873.6 KB - PDF)

Vis

Deutsch (DE) (889.37 KB - PDF)

Vis

eesti (ET) (830.81 KB - PDF)

Vis

ελληνικά (EL) (1.51 MB - PDF)

Vis

français (FR) (864.23 KB - PDF)

Vis

hrvatski (HR) (875.28 KB - PDF)

Vis

italiano (IT) (859.62 KB - PDF)

Vis

latviešu (LV) (1.25 MB - PDF)

Vis

lietuvių (LT) (810.52 KB - PDF)

Vis

magyar (HU) (1.25 MB - PDF)

Vis

Malti (MT) (1.26 MB - PDF)

Vis

Nederlands (NL) (855.45 KB - PDF)

Vis

polski (PL) (1.23 MB - PDF)

Vis

português (PT) (838.3 KB - PDF)

Vis

română (RO) (1 MB - PDF)

Vis

slovenčina (SK) (1.18 MB - PDF)

Vis

slovenščina (SL) (1.13 MB - PDF)

Vis

suomi (FI) (858.03 KB - PDF)

Vis

svenska (SV) (851.7 KB - PDF)

Vis

Íslenska (IS) (879.42 KB - PDF)

Vis

norsk (NO) (836.37 KB - PDF)

Vis
Latest procedure affecting product information:IB/0009/G
13/10/2016

български (BG) (498.29 KB - PDF)

Vis

español (ES) (458.29 KB - PDF)

Vis

čeština (CS) (487.32 KB - PDF)

Vis

dansk (DA) (460.34 KB - PDF)

Vis

Deutsch (DE) (460.75 KB - PDF)

Vis

eesti (ET) (460.29 KB - PDF)

Vis

ελληνικά (EL) (495.78 KB - PDF)

Vis

français (FR) (460.31 KB - PDF)

Vis

hrvatski (HR) (471.53 KB - PDF)

Vis

italiano (IT) (460.57 KB - PDF)

Vis

latviešu (LV) (491.15 KB - PDF)

Vis

lietuvių (LT) (475.45 KB - PDF)

Vis

magyar (HU) (485.61 KB - PDF)

Vis

Malti (MT) (488.27 KB - PDF)

Vis

Nederlands (NL) (458.26 KB - PDF)

Vis

polski (PL) (485.72 KB - PDF)

Vis

português (PT) (460.24 KB - PDF)

Vis

română (RO) (474.03 KB - PDF)

Vis

slovenčina (SK) (487.71 KB - PDF)

Vis

slovenščina (SL) (477.71 KB - PDF)

Vis

suomi (FI) (458.28 KB - PDF)

Vis

svenska (SV) (460.23 KB - PDF)

Vis

Íslenska (IS) (457.47 KB - PDF)

Vis

norsk (NO) (461.18 KB - PDF)

Vis

Product details

Name of medicine
Recuvyra
Active substance
fentanyl
International non-proprietary name (INN) or common name
fentanyl
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) code
QN02AB03

Pharmacotherapeutic group

Nervous system

Therapeutic indication

For the control of pain associated with orthopaedic and soft tissue surgery in dogs.

Authorisation details

EMA product number
EMEA/V/C/002239
Marketing authorisation holder
Eli Lilly and Company Limited 

Eli Lilly and Company Limited
Lilly House
Priestley Road
Basingstoke
Hampshire RG24 9NL
United Kingdom

Marketing authorisation issued
06/10/2011
Expiry of marketing authorisation
13/10/2016
Revision
4

Assessment history

This page was last updated on

Share this page